在中国对一种慢性阻塞性肺病筛查问卷的开发和验证

Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China
作者:Zhou, Y.-M., Chen, S.-Y., Tian, J., Cui, J.-Y., Li, X.-C., Hong, W., Zhao, Z.-X., Hu, G.-P., He, F., Qiu, R., Wang, X.-P., Wang, D.-L., Zheng, J.-P., Zhong, N.-S., Ran, P.
机构: 广州医学院附属第一医院呼吸疾病国家重点实验室
期刊: INT J TUBERC LUNG D2013年12月12期17卷

Abstract

OBJECTIVE:

To develop a brief, reliable screening questionnaire for chronic obstructive pulmonary disease (COPD) for use in primary care settings.

METHODS:

We developed a COPD Screening Questionnaire (COPD-SQ) using data collected from 19,800 subjects aged ≥40 years obtained from an epidemiological study of COPD in China in 2002 (Phase I). A stepwise logistic regression method was adopted for item reduction and scoring. We then assessed the COPD-SQ through a cross-sectional study (Phase II) among 3231 subjects aged ≥40 years.

RESULTS:

The final COPD-SQ consisted of seven items: age, smoking pack-years, body mass index, cough, dyspnoea, family history of respiratory diseases and exposure to biomass smoke from cooking. Using the questionnaire to screen for COPD in Phase II, we obtained high classification accuracy with an area under the curve of 0.812 (95%CI 0.786-0.838). The sensitivity, specificity and correct classification rates for COPD diagnosis were respectively 60.6%, 85.2% and 82.7% at a cut-off score of 16.

CONCLUSIONS:

The COPD-SQ can be used in first-level screening for COPD.

通讯作者:Ran, P.; State Key Laboratory of Respiratory Disease, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China; email:pxran@gzhmc.edu.cn
学科代码:传染病学   关键词:一种慢性阻塞性肺病 ,中国作者重要发表 爱思唯尔医学网, Elseviermed
来源: Scopus
Scopus介绍:Scopus 于2004年11月正式推出,是目前全球规模最大的文摘和引文数据库。Scopus涵盖了由5000多家出版商出版发行的科技、医学和社会科学方面的18,000多种期刊,其中同行评审期刊16,500多种。相对于其他单一的文摘索引数据库而言,Scopus的内容更加全面,学科更加广泛,特别是在获取欧洲及亚太地区的文献方面,用户可检索出更多的文献数量。通过Scopus,用户可以检索到1823年以来的近4000万条摘要和题录信息,以及1996年以来所引用的参考文献。数据每日更新。 马上访问Scopus网站http://www.scopus.com/
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录